In early-stage tumors, TGF-β exerts anti-tumor effects by promoting cell cycle arrest and apoptosis, while in advanced-stage tumors TGF-β promotes tumor metastasis and recurrence by promoting immunosuppression, promoting tumor angiogenesis, and inducing epithelial-mesenchymal transition (EMT) (119). This evidence concerns the gene TGFB1 and neoplasm.